Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...

The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

The brain of humans and other animals is known to contribute to the protection of the body from infections. Past studies have unveiled the existence of the so-called conditioned immune response (CIR), ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Vaxcyte has advanced to the Phase II trial’s second and final stage (Stage 2) assessing its 31-valent pneumococcal conjugate ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.